Our top pick for
Stericycle, Inc is a waste management business based in the US. Stericycle shares (SRCL) are listed on the NASDAQ and all prices are listed in US Dollars. Stericycle employs 19,500 staff and has a trailing 12-month revenue of around USD$2.8 billion.
|52-week range||USD$38.45 - USD$79.5|
|50-day moving average||USD$68.4736|
|200-day moving average||USD$66.9997|
|Wall St. target price||USD$77.14|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-4.114|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Stericycle stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stericycle's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stericycle's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0491. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stericycle's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stericycle's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$502.1 million.
The EBITDA is a measure of a Stericycle's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$2.8 billion|
|Operating margin TTM||9.17%|
|Gross profit TTM||USD$1.2 billion|
|Return on assets TTM||2.63%|
|Return on equity TTM||-13.46%|
|Market capitalisation||USD$6.2 billion|
TTM: trailing 12 months
There are currently 1.8 million Stericycle shares held short by investors – that's known as Stericycle's "short interest". This figure is 8.9% down from 2.0 million last month.
There are a few different ways that this level of interest in shorting Stericycle shares can be evaluated.
Stericycle's "short interest ratio" (SIR) is the quantity of Stericycle shares currently shorted divided by the average quantity of Stericycle shares traded daily (recently around 393872.29437229). Stericycle's SIR currently stands at 4.62. In other words for every 100,000 Stericycle shares traded daily on the market, roughly 4620 shares are currently held short.
However Stericycle's short interest can also be evaluated against the total number of Stericycle shares, or, against the total number of tradable Stericycle shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stericycle's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Stericycle shares in existence, roughly 20 shares are currently held short) or 0.0199% of the tradable shares (for every 100,000 tradable Stericycle shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stericycle.
Find out more about how you can short Stericycle stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stericycle.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32.41
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stericycle's overall score of 32.41 (as at 01/01/2019) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Stericycle is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 20.93/100
Stericycle's environmental score of 20.93 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Stericycle is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 12.14/100
Stericycle's social score of 12.14 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Stericycle is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.34/100
Stericycle's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Stericycle is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Stericycle scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Stericycle has, for the most part, managed to keep its nose clean.
|Total ESG score||32.41|
|Total ESG percentile||47.4|
|Environmental score percentile||7|
|Social score percentile||7|
|Governance score percentile||7|
|Level of controversy||2|
We're not expecting Stericycle to pay a dividend over the next 12 months.
Stericycle's shares were split on a 2:1 basis on 1 June 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stericycle shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stericycle shares which in turn could have impacted Stericycle's share price.
Over the last 12 months, Stericycle's shares have ranged in value from as little as $38.45 up to $79.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Stericycle's is 1.3943. This would suggest that Stericycle's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States, Europe, and internationally. It operates through three segments: North America RWCS; International RWCS; and Domestic Communication and Related Services. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, recall/return, and communication services. The company's services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is headquartered in Bannockburn, Illinois.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.